In addition, the results in vitro and mouse models indicated that silencing VDAC1 expression inhibited the growth of different cancer cells, including triple-negative breast cancer, suggesting VDAC1 was involved in the reprogramming of breast cancer cells metabolism, regardless of origin or mutational status [35]. This evidence concerns the gene VDAC1 and breast carcinoma.